Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association's 2026 Scientific Sessions

Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association's 2026 Scientific Sessions

PR Newswire

PLAINSBORO, NJ and BAGSVÆRD, Denmark, June 6, 2026

View original content to download multimedia:https://www.prnewswire.com/news-releases/novo-nordisk-to-present-new-data-on-wegovy-across-a-wide-range-of-cardiometabolic-conditions-at-the-american-diabetes-associations-2026-scientific-sessions-302793265.htmlSOURCE NOVO NORDISK INC.

The articles, information, and content displayed on this webpage may